The obese teen: the neuroendocrine connection.
According to the Centers for Disease Control and Prevention, the prevalence of obesity among adolescents ages 12 to 19 has soared in recent decades, from 5% in 1980 to 16% in 2002. Recent neuroendocrinologic research may help to explain the complexity of obesity and help providers develop more effective weight-loss strategies. Combining medical intervention with an individualized cognitive-behavioral program is the best approach for adolescents. Accompanying sidebars examine several such programs and provide additional resources for clinicians.
Hoeman
Laura D
LD
Behavioral Health Resources Acute Psychiatric Services, Olympia, WA, USA. laurahoemanarnp@aol.com
D000293:Adolescent; D000328:Adult; D019440:Anti-Obesity Agents / Q000009:adverse effects / Q000627:therapeutic use; D001521:Behavior Therapy / Q000379:methods / Q000458:organization & administration*; D002648:Child; D004644:Emotions; D005247:Feeding Behavior / Q000523:psychology; D005260:Female; D006801:Humans; D007783:Lactones / Q000009:adverse effects / Q000627:therapeutic use; D008297:Male; D009490:Neurosecretory Systems / Q000502:physiology*; D009767:Obesity, Morbid / Q000453:epidemiology / Q000235:genetics / Q000628:therapy; D000077403:Orlistat; D015431:Weight Loss / Q000187:drug effects
D019440:Anti-Obesity Agents; D007783:Lactones; D000077403:Orlistat